About DermaGen AB

DermaGen develops peptide therapeutics for topical use based on novel and proprietary antimicrobial peptides (AMPs). We intend to be a leading R&D company in this area with the aim of offering innovative and profitable licensing opportunities to selected pharmaceutical companies with significant market potential. DermaGen focuses on R&D to provide new and patented products initially for dermatological indications.

website icon
Website
employees icon
Employees
industry icon
Industry
Pharmaceutical Manufacturing
location icon
Headquarter
Scheelevägen 22, Lund, SE
description icon
Founded
2004

DermaGen AB Alternatives

Industry
Pharmaceuticals
Industry
Biotechnology
Industry
Medical Device
Industry
Pharmaceuticals
Industry
Biotechnology
Industry
Pharmaceuticals

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more